Bone Biologics Corporation

BBLG | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.48

-$0.04 (-7.51%)

At close: Sep 21, 2026, 4:00 PM ET

$0.47

-$0.01 (-1.23%)

After-hours: Sep 21, 2026, 6:47 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-7.51%

(1D)

Rating

Updated: Aug 26, 2026

Fundamentals Weak

Market Sentiment Bearish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $861.2K

1D Range

0.47 0.52

52W Range

0.43 2.89

Valuation (TTM)

PE -0.26

PB 0.22

EV/EBITDA 1.44

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target N/A

Cash Flow

FCF Yield -305.3%

SBC Adj. FCF Yield -324.4%

SBC Impact -6.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 75.8% | -50.0%

FCF 3Y | 5Y 48.9% | 4.9%

Returns

ROA -65.2%

ROE -57.9%

ROIC -78.0%

Financial Health

Net Cash

$4.03M

Current Ratio 8.67

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship produc...

Sector Healthcare

Industry Biotechnology

Employees 2

IPO Date Oct 12, 2021

Website www.bonebiologics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.